Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.

NCT00758628 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Bromefenac
DRUG: Blink

Sponsor

Bp Consulting, Inc